📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. (2022)

First Author: Dimiou S

Attributed to: Delivering antibodies (molecular weight = 150 kDa) to the brain funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2022.121658

PubMed Identifier: 35292396

Publication URI: http://europepmc.org/abstract/MED/35292396

Type: Journal Article/Review

Volume: 618

Parent Publication: International journal of pharmaceutics

ISSN: 0378-5173